Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human CSNK2B Protein, N-His

Catalog #:   YHF61501 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P67870
Protein length: Met1-Arg175
Overview

Catalog No.

YHF61501

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Met1-Arg175

Predicted molecular weight

22.48 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P67870

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

CSNK2B, G5A, CK2N, Protein G5a, Casein kinase II subunit beta, CK II beta, Phosvitin

Data Image
  • SDS-PAGE
    SDS PAGE for Recombinant Human CSNK2B Protein
References

Pathogenic missense variants of CSNK2B associated with Poirier-Bienvenu neurodevelopmental disorder impact differently on CK2 holoenzyme formation., PMID:40317201

Genetic analysis of four cases of Poirier Bienvenu neurodevelopmental syndrome associated with CSNK2B variant., PMID:40211296

Exploration of Circadian Clock-Related Genes in the Pathogenesis of Psoriatic Arthritis to Identify Potential Therapeutic Targets From Multi-Omics Insight: A Mendelian Randomization Study., PMID:40062439

Disruption of circadian intraocular pressure fluctuations in mice by the Lyst beige-J mutation., PMID:39894294

Curzerenone inactivates the nuclear factor-kappa B signaling to suppress malignancy and immune evasion in cervical cancer by targeting CSNK2B., PMID:39718697

Characterization of 13 Novel Genetic Variants in Genes Associated with Epilepsy: Implications for Targeted Therapeutic Strategies., PMID:39003674

Exploration of mitochondrial autophagy related genes in the diagnosis model construction and molecular marker mining of Alzheimer's disease based on multi-omics integration., PMID:38836671

RACK1 Promotes Meningioma Progression by Activation of NF-κB Pathway via Preventing CSNK2B from Ubiquitination Degradation., PMID:38398158

Genetic analysis and literature review of a Poirier-Bienvenu neurodevelopmental syndrome family line caused by a de novo frameshift variant in CSNK2B., PMID:38037515

CSNK2 suppresses autophagy by activating FLN-NHL-containing TRIM proteins., PMID:37938186

Proteomic analysis of anti-aging effects of Dendrobium nobile Lindl. alkaloids in aging-accelerated SAMP8 mice., PMID:37150330

CSNK2B modulates IRF1 binding to functional DNA elements and promotes basal and agonist-induced antiviral signaling., PMID:37094077

Long noncoding RNA HIKER regulates erythropoiesis in Monge's disease via CSNK2B., PMID:37022795

Haploinsufficiency as a Foreground Pathomechanism of Poirer-Bienvenu Syndrome and Novel Insights Underlying the Phenotypic Continuum of CSNK2B-Associated Disorders., PMID:36833176

Identification of radiation responsive RBC membrane associated proteins (RMAPs) in whole-body γ-irradiated New Zealand white rabbits., PMID:36718137

MicroRNA-1205 Suppresses Hepatocellular Carcinoma Cell Proliferation via a CSNK2B/CDK4 Axis., PMID:36617978

In Skeletal Muscle Fibers, Protein Kinase Subunit CSNK2A1/CK2α Is Required for Proper Muscle Homeostasis and Structure and Function of Neuromuscular Junctions., PMID:36552726

Predictive functional, statistical and structural analysis of CSNK2A1 and CSNK2B variants linked to neurodevelopmental diseases., PMID:36310603

De novo variants of CSNK2B cause a new intellectual disability-craniodigital syndrome by disrupting the canonical Wnt signaling pathway., PMID:35571680

Proteomic profiling of postmortem prefrontal cortex tissue of suicide completers., PMID:35383147

Identification of a seven-gene prognostic signature using the gene expression profile of osteosarcoma., PMID:35282067

Regulation of sclerostin by the SIRT1 stabilization pathway in osteocytes., PMID:35169297

Where all the Roads Meet? A Crossover Perspective on Host Factors Regulating SARS-CoV-2 infection., PMID:34914966

Clinical and genetic analysis of six Chinese children with Poirier-Bienvenu neurodevelopmental syndrome caused by CSNK2B mutation., PMID:34370157

6p21.33 Deletion encompassing CSNK2B is associated with relative macrocephaly, facial dysmorphism, and mild intellectual disability., PMID:33758130

Overexpression of NELFE contributes to gastric cancer progression via Wnt/β-catenin signaling-mediated activation of CSNK2B expression., PMID:33526068

Genome-wide CRISPR screens reveal multitiered mechanisms through which mTORC1 senses mitochondrial dysfunction., PMID:33483422

Poirier-Bienvenu neurodevelopmental syndrome: A report of a patient with a pathogenic variant in CSNK2B with abnormal linear growth., PMID:33166063

Antitumor Activity and Mechanism of Robustic Acid from Dalbergia benthami Prain via Computational Target Fishing., PMID:32867345

Activating Transcription Factor 6 Mediates Inflammatory Signals in Intestinal Epithelial Cells Upon Endoplasmic Reticulum Stress., PMID:32673694

Proteins of Wnt signaling pathway in cancer stem cells of human glioblastoma., PMID:32448607

Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma., PMID:31901862

Germline de novo variants in CSNK2B in Chinese patients with epilepsy., PMID:31784560

Protein Kinase CK2 Subunits Differentially Perturb the Adhesion and Migration of GN11 Cells: A Model of Immature Migrating Neurons., PMID:31779225

Loss of Protein Kinase Csnk2b/CK2β at Neuromuscular Junctions Affects Morphology and Dynamics of Aggregated Nicotinic Acetylcholine Receptors, Neuromuscular Transmission, and Synaptic Gene Expression., PMID:31434353

Comprehensive functional annotation of susceptibility SNPs prioritized 10 genes for schizophrenia., PMID:30705251

Identification of de novo CSNK2A1 and CSNK2B variants in cases of global developmental delay with seizures., PMID:30655572

Comprehensive integrative analyses identify GLT8D1 and CSNK2B as schizophrenia risk genes., PMID:29483533

In mammalian skeletal muscle, phosphorylation of TOMM22 by protein kinase CSNK2/CK2 controls mitophagy., PMID:29165030

Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer., PMID:29071797

Truncating mutation in CSNK2B and myoclonic epilepsy., PMID:28762608

CSNK2B splice site mutations in patients cause intellectual disability with or without myoclonic epilepsy., PMID:28585349

Atherosclerosis-Driven Treg Plasticity Results in Formation of a Dysfunctional Subset of Plastic IFNγ+ Th1/Tregs., PMID:27635087

Validation of a network-based strategy for the optimization of combinatorial target selection in breast cancer therapy: siRNA knockdown of network targets in MDA-MB-231 cells as an in vitro model for inhibition of tumor development., PMID:27527857

Novel Anthra[1,2-c][1,2,5]Thiadiazole-6,11-Diones as Promising Anticancer Lead Compounds: Biological Evaluation, Characterization & Molecular Targets Determination., PMID:27100886

RNA-seq analysis of hippocampal tissues reveals novel candidate genes for drug refractory epilepsy in patients with MTLE-HS., PMID:27094248

Integrated molecular analysis of adult T cell leukemia/lymphoma., PMID:26437031

Systematic analysis of circadian genes using genome-wide cDNA microarrays in the inflammatory bowel disease transcriptome., PMID:26172092

Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy., PMID:25837326

Quantitative proteome profiling of human myoma and myometrium tissue reveals kinase expression signatures with potential for therapeutic intervention., PMID:25327614

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human CSNK2B Protein, N-His [YHF61501]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only